Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer

Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer

Cannabidiol, a major non-psychotomimetic compound derived from <i>Cannabis sativa</i>, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-rel...

Full description

Bibliographic Details
Main Authors: Jung Lim Kim, Bo Ram Kim, Dae Yeong Kim, Yoon A. Jeong, Soyeon Jeong, Yoo Jin Na, Seong Hye Park, Hye Kyeong Yun, Min Jee Jo, Bu Gyeom Kim, Han Do Kim, Dae Hyun Kim, Sang Cheul Oh, Sun Il Lee, Dae-Hee Lee
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
cannabidiol
TNF-related apoptosis-inducing ligand
death receptor 5
endoplasmic reticulum stress
Online Access:https://www.mdpi.com/2072-6694/11/5/642

Internet

https://www.mdpi.com/2072-6694/11/5/642

Similar Items